Trybe Capital Management LP
- SEC CIK
- 0001807902
- Latest filing
- Aug 14, 2026
DNA holding history
Ginkgo Bioworks Holdings, Inc. in every 13F filed by Trybe Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNA overviewAll 13F holders of DNAFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −3,780,776−100.0% | Sold out | Holders |
| Q2 2023 | 3,780,776 | $7.03M | 4.1% | +2,726,433+258.6% | Added | Holders |
| Q1 2023 | 1,054,343 | $1.40M | 1.3% | +1,054,343 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −1,054,343−100.0% | Sold out | Holders |
| Q3 2022 | 1,054,343 | $3.29M | 3.3% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,054,343 | $2.51M | 2.2% | −153,649−12.7% | Reduced | Holders |
| Q1 2022 | 1,207,992 | $4.87M | 3.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,207,992 | $10.0M | 5.3% | 00.0% | Unchanged | Holders |
| Q3 2021 | 1,207,992 | $14.0M | 8.0% | +1,207,992 | New | Holders |